S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AMRX Amneal Pharmaceuticals Inc

8.90

0.14 (1.60%)

Mar 07 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Amneal Pharmaceuticals (NASDAQ:AMRX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Amneal Pharmaceuticals Charts.

Amneal Pharmaceuticals (NASDAQ:AMRX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Amneal Pharmaceuticals Charts.

Amneal Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 5 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 5 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 March 2025 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 28 February 2025 (1 week ago) • Edgar (US Regulatory)

Amneal Reports Fourth Quarter and Full Year 2024 Financial Results
Friday 28 February 2025 (1 week ago) • Business Wire

Amneal Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide
Wednesday 19 February 2025 (3 weeks ago) • Business Wire

More Amneal Pharmaceuticals Inc News Articles

Global X S&p 500 Covered...

Endurance Capital

Portofino Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions